Empirical treatment

(Date:5/15/2008)...POLIS, May 15 /PRNewswire-FirstCall/ -- Lung cance...ent decisions may fare better as a,result, accordi...er (NSCLC),clinical trial. Data from the trial, wh...metrexed for injection), will be presented at the ...nical Oncology (ASCO) in Chicago,Ill., May 30 -- ...

(Date:5/15/2008)...n, DC -- With the goal of tailoring cancer treatme...University Medical Center today presented a study ...re reliably assess treatment efficacy for patients...veral weeks and sometimes months to determine if a... can take that long to observe any significant rad...

(Date:5/15/2008)...USTON - Celecoxib, the anti-inflammatory medicatio...n to be safe and reduces a specific proliferation ...ccording to a study from The University of Texas M...ates the significance of COX-2 inhibition toward p...k of developing the disease. , The study is the ...

(Date:5/15/2008)..., China, May 15 /Xinhua-PRNewswire-FirstCall/ -- G...etin Board: GTEC) ("Genesis" or,the "Company"), a ...rations,in the People,s Republic of China, today a...ed March 31, 2008, the Company,s third quarter of ...was filed for the quarter,with the U.S. Securities...

...esearch and Learning Disabilities and Prof. Baruch...niversity of Haifa have developed a standardized t...lities. The project was headed by Prof. Zvia Bre...Brain Research and Learning Disabilities at the Un...

...ducing obesity among American consumers, but some ...beneficial in the battle against the bulge accordi...hed monthly by the Institute of Food Technologists...cent food science, nutrition and metabolic researc...

...y provide effective protection against HIV was wel...HO) and the UNAIDS Secretariat. It follows public...Kenya and Uganda in the medical journal The Lancet...er study by the South Africa Orange Farm Intervent...

...n-one fixed dose combination Atripla in 66 develop...th Organization prequalification for the product, ...is a single tablet containing a daily dose of efav...ll be priced at $613 a year for least developed co...